OncoHealth is developing high-throughput screening products utilizing its own proprietary biomarkers for direct detection of human papilloma virus (HPV) E6E7 oncoproteins present during the development of cervical and other HPV-related cancers.
December 3, 2012 New data demonstrate ability of OncoHealth’s HPV E6/E7 assays to help differentiate cervical disease from clinically insignificant HPV infections.